INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$262K
2,160 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

Page 315 of 531
← PrevNext →
29
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL
$501K
535 sh
Apr 23, 2026
Apr 24, 2026
traded Apr 23, 2026
+1d
SEC Form 4

Evidence

29
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$544K
581 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

28
RA
Reid Jeffrey A.EVP, Chief HR Officer
BOKFBOK FINANCIAL CORP
Open-market sale
SELL$148K
1,095 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
540 sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

25
SS
Stout Jay SChief Technology Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$82K
2,754 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

21
RA
Reid Jeffrey A.EVP, Chief HR Officer
BOKFBOK FINANCIAL CORP
Open-market sale
SELL$14K
105 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

19
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$269K
19.1K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

14
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$205K
2,281 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

11
HC
Hamilton James CChief Medical Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$750K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

9
MC
McDonough ClaireChief Financial Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$184K
10.2K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

6
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$144K
40.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$267K
19.1K sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$262K
19.1K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$31K
10.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,250 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC Form 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$29K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.43M
12.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

43
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Open-market sale
SELL$2.11M
23.4K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

41
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
3,255 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

41
DN
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER
SGMOSANGAMO THERAPEUTICS, INC
Open-market sale
SELL$89K
345.9K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
PM
Peterson MichaelEXECUTIVE VICE PRESIDENT
SEICSEI INVESTMENTS CO
Open-market sale
SELL$900K
10.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.83M
15.5K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.66M
49.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.57M
22.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

39
PL
Patrick Deval LDirector
TOSTToast, Inc.
Open-market sale
SELL$62K
1,667 sh
Jan 9, 2025Apr 23, 2026
traded Jan 9, 2025
+469dSEC Form 4

Evidence

35
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market sale
SELL$5.27M
1.50M sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
350 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$10.51M
90.9K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

34
DD
Davis Gregory DHead of Research & Technology
SGMOSANGAMO THERAPEUTICS, INC
Open-market sale
SELL$18K
69.8K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

33
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$620K
5,404 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.78M
41.1K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.39M
28.8K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.65M
22.4K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.15M
10.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$721K
6,045 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

29
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Open-market sale
SELL$141K
1,559 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

26
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$356K
9,100 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
650 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

25
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$112K
1,754 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence